대규모 및 소규모 바이오프로세싱 시장 규모, 점유율, 동향 분석 보고서 : 규모별, 워크플로우별, 제품별, 용도별, 사용 유형별, 모드별, 지역별, 부문별 예측(2026-2033년)
Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Scale, By Workflow (Downstream, Upstream), By Product, By Application, By Use Type, By Mode (In-house, Outsourced), By Region, And Segment Forecasts, 2026 - 2033
상품코드
:
1908608
리서치사
:
Grand View Research
발행일
:
2025년 12월
페이지 정보
:
영문 120 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
대규모 및 소규모 바이오프로세싱 시장 개요
세계의 대규모 및 소규모 바이오프로세싱 시장 규모는 2025년에 933억 2,000만 달러로 추정되며, 2033년에 2,287억 3,000만 달러에 달할 것으로 예측됩니다.
2026년부터 2033년까지 CAGR 11.39%로 성장할 것으로 예상됩니다. 이 같은 성장의 주요 원인은 단클론항체, 백신, 세포 및 유전자 치료제를 포함한 생물학적 제제에 대한 전 세계 수요 증가에 기인합니다.
바이오 제약 기업들은 개발 기간 단축과 생산 비용 절감에 기여하는 일회용 기술 및 모듈형 바이오프로세싱 시스템과 같은 유연한 제조 솔루션에 많은 투자를 하고 있습니다.
목차 제1장 조사 방법과 범위
제2장 주요 요약
제3장 대규모 및 소규모 바이오프로세싱 시장의 변수, 동향과 범위
시장 계통 전망
시장 역학
대규모 및 소규모 바이오프로세싱 시장 분석 툴
산업 분석 : Porter's Five Forces
PESTEL 분석
제4장 대규모 및 소규모 바이오프로세싱 시장 : 규모별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 규모 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(규모별, 2021-2033년)
산업 규모(50,000리터 이상)
소규모(50,000리터 이하)
제5장 대규모 및 소규모 바이오프로세싱 시장 : 제품별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 제품 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(제품별, 2021-2033년)
바이오 원자로/발효조
세포배양 제품
바이오 원자로 부속품
여과 어셈블리
백과 용기
기타
제6장 대규모 및 소규모 바이오프로세싱 시장 : 용도별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 용도 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(용도별, 2021-2033년)
바이오의약품
특수 산업용 화학제품
환경 보조제
제7장 대규모 및 소규모 바이오프로세싱 시장 : 사용 유형별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 사용 유형 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(사용 유형별, 2021-2033년)
다회용
일회용
제8장 대규모 및 소규모 바이오프로세싱 시장 : 모드별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 모드 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(모드별, 2021-2033년)
자사내
외부 위탁
제9장 대규모 및 소규모 바이오프로세싱 시장 : 워크플로우별, 추정·동향 분석
세계의 대규모 및 소규모 바이오프로세싱 시장의 워크플로우 변동 분석
세계의 대규모 및 소규모 바이오프로세싱 시장 규모와 동향 분석(워크플로우별, 2021-2033년)
다운스트림 프로세싱
발효
업스트림 프로세싱
제10장 대규모 및 소규모 바이오프로세싱 시장 : 지역별, 추정·동향 분석
지역별 시장 점유율 분석(2025년과 2033년)
지역별 시장 대시보드
시장 규모와 예측 동향 분석, 2021-2033년
북미
유럽
영국
독일
프랑스
이탈리아
스페인
노르웨이
스웨덴
덴마크
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제11장 경쟁 구도
기업/경쟁 분류
전략 매핑
2025년의 기업 시장 상황 분석
기업 개요/리스트
Merck KGaA
Thermo Fisher Scientific, Inc.
Danaher(Cytiva)
Corning, Inc.
Sartorius AG
CESCO BIOENGINEERING CO., LTD
Bio-Process Group
BPC Instruments AB
Eppendorf AG
Getinge AB
Lonza
PBS BIoTech, Inc
Bio-Synthesis, Inc.
Meissner Filtration Products, Inc.
Entegris
KUHNER AG
Saint-Gobain
ExcellGene SA
Repligen Corporation
Avantor, Inc
CerCell A/S
Univercells Technologies
Distek, Inc.
F. Hoffmann-La Roche Ltd
KSM
영문 목차
Large And Small-scale Bioprocessing Market Summary
The global large and small-scale bioprocessing market size was estimated at USD 93.32 billion in 2025 and is expected to reach USD 228.73 billion by 2033, growing at a CAGR of 11.39% from 2026 to 2033. This substantial growth is primarily driven by the increasing global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.
Biopharmaceutical companies invest significantly in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, which help accelerate development timelines and reduce production costs.
Global Large And Small-scale Bioprocessing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global large- and small-scale bioprocessing market report on the basis of scale, workflow, product, application, use type, mode, and region.
Scale Outlook (Revenue, USD Million, 2021 - 2033)
Industrial Scale (Over 50,000 Liter)
Small Scale (Less Than 50,000 Liter)
Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Downstream Processing
Fermentation
Upstream Processing
Product Outlook (Revenue, USD Million, 2021 - 2033)
Bioreactors/Fermenters
Cell Culture Products
Filtration Assemblies
Bioreactors Accessories
Bags & Containers
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceuticals
Specialty Industrial Chemicals
Environmental Aids
Use Type Outlook (Revenue, USD Million, 2021 - 2033)
Multi-Use
Single-Use
Mode Outlook (Revenue, USD Million, 2021 - 2033)
In-house
Outsourced
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. SCALE
1.2.2. WORKFLOW
1.2.3. PRODUCT
1.2.4. APPLICATION
1.2.5. MODE
1.2.6. USE TYPE
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Large- and Small-Scale Bioprocessing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing implementation of single-use technology (SUT) for bioproduction
3.2.1.2. Rising demand for biologics
3.2.2. Market restraint analysis
3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
3.2.2.2. Complexity and regulatory hurdles
3.3. Large- and small-scale bioprocessing Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Large- and Small-Scale Bioprocessing Market: Scale Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Large- and Small-Scale Bioprocessing Market Service Scale Movement Analysis
4.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
4.4. Industrial Scale (Over 50,000 Liter)
4.4.1. Industrial Scale (Over 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Small Scale (Less Than 50,000 Liter)
4.5.1. Small Scale (Less Than 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Large- and Small-Scale Bioprocessing Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Large- and Small-Scale Bioprocessing Market Product Movement Analysis
5.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Bioreactors/Fermenters
5.4.1. Bioreactors/Fermenters market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Cell Culture Products
5.5.1. Cell Culture Products market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Bioreactors Accessories
5.6.1. Bioreactors Accessories market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Filtration Assemblies
5.7.1. Filtration Assemblies market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Bags & Containers
5.8.1. Bags & Containers market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Large- and Small-Scale Bioprocessing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Large- and Small-Scale Bioprocessing Market Application Movement Analysis
6.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Biopharmaceuticals
6.4.1. Biopharmaceuticals market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Specialty Industrial Chemicals
6.5.1. Specialty Industrial Chemicals market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Environmental Aids
6.6.1. Environmental Aids market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Large- and Small-Scale Bioprocessing Market: Use Type Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Large- and Small-Scale Bioprocessing Market Use Type Movement Analysis
7.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Use Type, 2021 to 2033 (USD Million)
7.4. Multi-Use
7.4.1. . Multi-Use market estimates and forecasts 2021 to 2033 (USD Million)
7.5. . Single-Use
7.5.1. Single-Use market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Large- and Small-Scale Bioprocessing Market: Mode Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Large- and Small-Scale Bioprocessing Market Mode Movement Analysis
8.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
8.4. . In-House
8.4.1. In-House market estimates and forecasts 2021 to 2033 (USD Million)
8.5. . Outsourced
8.5.1. Outsourced market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Large- and Small-Scale Bioprocessing Market: Workflow Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Global Large- and Small-Scale Bioprocessing Market Workflow Movement Analysis
9.3. Global Large- and Small-Scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
9.4. Downstream Processing
9.4.1. Downstream Processing market estimates and forecasts 2021 to 2033 (USD Million)
9.5. Fermentation
9.5.1. Fermentation market estimates and forecasts 2021 to 2033 (USD Million)
9.6. Upstream Processing
9.6.1. Upstream Processing market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Large- and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis
10.1. Regional Market Share Analysis, 2025 & 2033
10.2. Regional Market Dashboard
10.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
10.4. North America
10.4.1. U.S.
10.4.1.1. Key country dynamics
10.4.1.2. Regulatory Framework
10.4.1.3. Competitive scenario
10.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
10.4.2. Canada
10.4.2.1. Key country dynamics
10.4.2.2. Regulatory Framework
10.4.2.3. Competitive scenario
10.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
10.4.3. Mexico
10.4.3.1. Key country dynamics
10.4.3.2. Competitive scenario
10.4.3.3. Regulatory Framework
10.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
10.5. Europe
10.5.1. UK
10.5.1.1. Key country dynamics
10.5.1.2. Competitive scenario
10.5.1.3. Regulatory Framework
10.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
10.5.2. Germany
10.5.2.1. Key country dynamics
10.5.2.2. Competitive scenario
10.5.2.3. Regulatory Framework
10.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
10.5.3. France
10.5.3.1. Key country dynamics
10.5.3.2. Competitive scenario
10.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
10.5.4. Italy
10.5.4.1. Key country dynamics
10.5.4.2. Competitive scenario
10.5.4.3. Regulatory Framework
10.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
10.5.5. Spain
10.5.5.1. Key country dynamics
10.5.5.2. Competitive scenario
10.5.5.3. Regulatory Framework
10.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
10.5.6. Norway
10.5.6.1. Key country dynamics
10.5.6.2. Competitive scenario
10.5.6.3. Regulatory Framework
10.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
10.5.7. Sweden
10.5.7.1. Key country dynamics
10.5.7.2. Competitive scenario
10.5.7.3. Regulatory Framework
10.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
10.5.8. Denmark
10.5.8.1. Key country dynamics
10.5.8.2. Competitive scenario
10.5.8.3. Regulatory Framework
10.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
10.6. Asia Pacific
10.6.1. Japan
10.6.1.1. Key country dynamics
10.6.1.2. Competitive scenario
10.6.1.3. Regulatory Framework
10.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
10.6.2. China
10.6.2.1. Key country dynamics
10.6.2.2. Competitive scenario
10.6.2.3. Regulatory Framework
10.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
10.6.3. India
10.6.3.1. Key country dynamics
10.6.3.2. Competitive scenario
10.6.3.3. Regulatory Framework
10.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
10.6.4. Australia
10.6.4.1. Key country dynamics
10.6.4.2. Competitive scenario
10.6.4.3. Regulatory Framework
10.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
10.6.5. South Korea
10.6.5.1. Key country dynamics
10.6.5.2. Competitive scenario
10.6.5.3. Regulatory Framework
10.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
10.6.6. Thailand
10.6.6.1. Key country dynamics
10.6.6.2. Competitive scenario
10.6.6.3. Regulatory Framework
10.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
10.7. Latin America
10.7.1. Brazil
10.7.1.1. Key country dynamics
10.7.1.2. Competitive scenario
10.7.1.3. Regulatory Framework
10.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
10.7.2. Argentina
10.7.2.1. Key country dynamics
10.7.2.2. Competitive scenario
10.7.2.3. Regulatory Framework
10.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
10.8. Middle East and Africa
10.8.1. South Africa
10.8.1.1. Key country dynamics
10.8.1.2. Competitive scenario
10.8.1.3. Regulatory Framework
10.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
10.8.2. Saudi Arabia
10.8.2.1. Key country dynamics
10.8.2.2. Competitive scenario
10.8.2.3. Regulatory Framework
10.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
10.8.3. UAE
10.8.3.1. Key country dynamics
10.8.3.2. Competitive scenario
10.8.3.3. Regulatory Framework
10.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
10.8.4. Kuwait
10.8.4.1. Key country dynamics
10.8.4.2. Competitive scenario
10.8.4.3. Regulatory Framework
10.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company/Competition Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2025
11.4. Company Profiles/Listing
11.4.1. Merck KGaA
11.4.1.1. Company overview
11.4.1.2. Financial performance
11.4.1.3. Product benchmarking
11.4.1.4. Strategic initiatives
11.4.2. Thermo Fisher Scientific, Inc.
11.4.2.1. Company overview
11.4.2.2. Financial performance
11.4.2.3. Product benchmarking
11.4.2.4. Strategic initiatives
11.4.3. Danaher (Cytiva)
11.4.3.1. Company overview
11.4.3.2. Financial performance
11.4.3.3. Product benchmarking
11.4.3.4. Strategic initiatives
11.4.4. Corning, Inc.
11.4.4.1. Company overview
11.4.4.2. Financial performance
11.4.4.3. Product benchmarking
11.4.4.4. Strategic initiatives
11.4.5. Sartorius AG
11.4.5.1. Company overview
11.4.5.2. Financial performance
11.4.5.3. Product benchmarking
11.4.5.4. Strategic initiatives
11.4.6. CESCO BIOENGINEERING CO., LTD
11.4.6.1. Company overview
11.4.6.2. Financial performance
11.4.6.3. Product benchmarking
11.4.6.4. Strategic initiatives
11.4.7. Bio-Process Group
11.4.7.1. Company overview
11.4.7.2. Financial performance
11.4.7.3. Product benchmarking
11.4.7.4. Strategic initiatives
11.4.8. BPC Instruments AB
11.4.8.1. Company overview
11.4.8.2. Financial performance
11.4.8.3. Product benchmarking
11.4.8.4. Strategic initiatives
11.4.9. Eppendorf AG
11.4.9.1. Company overview
11.4.9.2. Financial performance
11.4.9.3. Product benchmarking
11.4.9.4. Strategic initiatives
11.4.10. Getinge AB
11.4.10.1. Company overview
11.4.10.2. Financial performance
11.4.10.3. Product benchmarking
11.4.10.4. Strategic initiatives
11.4.11. Lonza
11.4.11.1. Company overview
11.4.11.2. Financial performance
11.4.11.3. Product benchmarking
11.4.11.4. Strategic initiatives
11.4.12. PBS Biotech, Inc
11.4.12.1. Company overview
11.4.12.2. Financial performance
11.4.12.3. Product benchmarking
11.4.12.4. Strategic initiatives
11.4.13. Bio-Synthesis, Inc.
11.4.13.1. Company overview
11.4.13.2. Financial performance
11.4.13.3. Product benchmarking
11.4.13.4. Strategic initiatives
11.4.14. Meissner Filtration Products, Inc.
11.4.14.1. Company overview
11.4.14.2. Financial performance
11.4.14.3. Product benchmarking
11.4.14.4. Strategic initiatives
11.4.15. Entegris
11.4.15.1. Company overview
11.4.15.2. Financial performance
11.4.15.3. Product benchmarking
11.4.15.4. Strategic initiatives
11.4.16. KUHNER AG
11.4.16.1. Company overview
11.4.16.2. Financial performance
11.4.16.3. Product benchmarking
11.4.16.4. Strategic initiatives
11.4.17. Saint-Gobain
11.4.17.1. Company overview
11.4.17.2. Financial performance
11.4.17.3. Product benchmarking
11.4.17.4. Strategic initiatives
11.4.18. ExcellGene SA
11.4.18.1. Company overview
11.4.18.2. Financial performance
11.4.18.3. Product benchmarking
11.4.18.4. Strategic initiatives
11.4.19. Repligen Corporation
11.4.19.1. Company overview
11.4.19.2. Financial performance
11.4.19.3. Product benchmarking
11.4.19.4. Strategic initiatives
11.4.20. Avantor, Inc
11.4.20.1. Company overview
11.4.20.2. Financial performance
11.4.20.3. Product benchmarking
11.4.20.4. Strategic initiatives
11.4.21. CerCell A/S
11.4.21.1. Company overview
11.4.21.2. Financial performance
11.4.21.3. Product benchmarking
11.4.21.4. Strategic initiatives
11.4.22. Univercells Technologies
11.4.22.1. Company overview
11.4.22.2. Financial performance
11.4.22.3. Product benchmarking
11.4.22.4. Strategic initiatives
11.4.23. Distek, Inc.
11.4.23.1. Company overview
11.4.23.2. Financial performance
11.4.23.3. Product benchmarking
11.4.23.4. Strategic initiatives
11.4.24. F. Hoffmann-La Roche Ltd
11.4.24.1. Company overview
11.4.24.2. Financial performance
11.4.24.3. Product benchmarking
11.4.24.4. Strategic initiatives
관련자료
